Peroxisome proliferator–activated receptor-γ coactivator-1α overexpression increases lipid oxidation in myocytes from extremely obese individuals

LA Consitt, JA Bell, TR Koves, DM Muoio… - Diabetes, 2010 - Am Diabetes Assoc
LA Consitt, JA Bell, TR Koves, DM Muoio, MW Hulver, KR Haynie, GL Dohm, JA Houmard
Diabetes, 2010Am Diabetes Assoc
OBJECTIVE To determine whether the obesity-related decrement in fatty acid oxidation
(FAO) in primary human skeletal muscle cells (HSkMC) is linked with lower mitochondrial
content and whether this deficit could be corrected via overexpression of peroxisome
proliferator–activated receptor-γ coactivator-1α (PGC-1α). RESEARCH DESIGN AND
METHODS FAO was studied in HSkMC from lean (BMI 22.4±0.9 kg/m2; N= 12) and
extremely obese (45.3±1.4 kg/m2; N= 9) subjects. Recombinant adenovirus was used to …
OBJECTIVE
To determine whether the obesity-related decrement in fatty acid oxidation (FAO) in primary human skeletal muscle cells (HSkMC) is linked with lower mitochondrial content and whether this deficit could be corrected via overexpression of peroxisome proliferator–activated receptor-γ coactivator-1α (PGC-1α).
RESEARCH DESIGN AND METHODS
FAO was studied in HSkMC from lean (BMI 22.4 ± 0.9 kg/m2; N = 12) and extremely obese (45.3 ± 1.4 kg/m2; N = 9) subjects. Recombinant adenovirus was used to increase HSkMC PGC-1α expression (3.5- and 8.0-fold), followed by assessment of mitochondrial content (mtDNA and cytochrome C oxidase IV [COXIV]), complete (14CO2 production from labeled oleate), and incomplete (acid soluble metabolites [ASM]) FAO, and glycerolipid synthesis.
RESULTS
Obesity was associated with a 30% decrease (P < 0.05) in complete FAO, which was accompanied by higher relative rates of incomplete FAO ([14C]ASM production/14CO2), increased partitioning of fatty acid toward storage, and lower (P < 0.05) mtDNA (−27%), COXIV (−35%), and mitochondrial transcription factor (mtTFA) (−43%) protein levels. PGC-1α overexpression increased (P < 0.05) FAO, mtDNA, COXIV, mtTFA, and fatty acid incorporation into triacylglycerol in both lean and obese groups. Perturbations in FAO, triacylglycerol synthesis, mtDNA, COXIV, and mtTFA in obese compared with lean HSkMC persisted despite PGC-1α overexpression. When adjusted for mtDNA and COXIV content, FAO was equivalent between lean and obese groups.
CONCLUSION
Reduced mitochondrial content is related to impaired FAO in HSkMC derived from obese individuals. Increasing PGC-1α protein levels did not correct the obesity-related absolute reduction in FAO or mtDNA content, implicating mechanisms other than PGC-1α abundance.
Am Diabetes Assoc